This study aimed to determine the role C5aR1 plays in mediating immune responses acutely after pilocarpine-induced status epilepticus (SE), specifically those of braininfiltrating leukocytes. Three days following pilocarpine SE, we determined by flow cytometry the brain immune cell phenotypes and measured key proinflammatory and antiinflammatory cytokine expression by infiltrating leukocytes and microglia in C5aR1-deficient and wild-type mice. Absence of C5aR1 reduced by 47% the numbers of Ly6G + neutrophils in the brains of No-SE mice and decreased neutrophil entry after SE to levels found in wild-type brains that did not undergo SE (No-SE). Moreover, C5aR1-deficient mice showed increased interleukin (IL)-4 expression in infiltrating leukocytes, but not in microglia. Increases in IL-4 expression in infiltrating leukocytes coupled with decreased neutrophil invasion in C5aR1-deficient mice after SE is likely to contribute to the reduced neuronal loss previously found in these mice compared to their wild-type littermates. Although other SE models need to be investigated to substantiate our findings, this study provides further evidence that C5aR1 is an inflammatory mediator and may play a role in epileptogenesis.
Inflammation plays a complex role in epilepsy pathophysiology and seizure initiation and can be targeted by new treatments. 1 Proinflammatory cytokines such as interleukin (IL)-1b and tumor necrosis factor a (TNFa) are highly involved not only in neurodegeneration but also central nervous system (CNS) hyperexcitability. 2, 3 Recently, we have shown that signaling of the innate immune complement system through the C5a complement receptor 1 (C5aR1) can promote seizures and post-SE cell death in several murine epilepsy models. Inhibition of C5aR1 using the receptor antagonist PMX53 was anticonvulsant in several paradigms, including acute and chronic electroencephalographic seizure models. 4, 5 In addition, hippocampal neuron death 3 days after pilocarpine-induced status epilepticus (SE) of similar severity was reduced by C5aR1 deficiency or pharmacologic inhibition after SE. Furthermore, C5aR1 deficiency leads to ablation of TNFa upregulation by microglia following pilocarpine SE. 4 Previous evidence suggests that C5aR1 may have an effect on the infiltrating leukocyte response after pilocarpineinduced SE. Pilocarpine, a muscarinic agonist, stimulates inflammation in the periphery, for example, via muscarinic receptors expressed by leukocytes, and acts in the CNS inducing epileptic seizures. 6 C5aR1 can contribute to blood-brain barrier (BBB) leakage, specifically by inducing caspase-3 activation and downregulation of tight-junction protein ZO-1 expression in endothelial cells. 7 Herein we show that C5aR1 is involved in modulating the acute response of infiltrating immune cells 3 days after pilocarpine-induced SE.
Methods

Mice
Nine-week-old male Swiss CD1 mice (Animal Resources Centre (ARC), Western Australia) were used for all experiments. Animals were housed individually on a 12 h light/dark cycle and had free access to food and water. C57/ BL6 C5aR1 À/À (Australian Institute for Bioengineering and Nanotechnology, Queensland, Australia) mice were bred into the CD1 background using five generation crosses. Genotypes of littermates born to heterozygous parents were determined with use of polymerase chain reaction (PCR) prior to use. All experiments were approved by The University of Queensland Animal Ethics Committee and conducted in accordance with their guidelines.
Pilocarpine model of status epilepticus
The mice used here were described previously and showed similar SE severity. 4 Mice were administered methyl scopolamine (2.5 mg/kg, i.p., in saline) 15 min prior to injection of 345 mg/kg (s.c.) pilocarpine, which induced SE in ≥60% of mice with 10% mortality. Ninety minutes post-pilocarpine, all mice were given 30 mg/kg (i.p.) pentobarbitone to stop SE. Inflammation is obvious within the first 24 h and neuronal cell death occurs in the hippocampal CA1 and CA3 pyramidal areas within 3 days post-SE. There is no real silent period in this model, and spontaneous recurrent seizures, and astrogliosis occur within the first few days post-SE. 4, 5 No-SE mice do not develop any of these changes. 5 
Flow cytometry
Cells were isolated from saline-perfused forebrains 3 days post-SE as described previously, 8 
Results
No change in C5aR1 expression on leukocytes post-SE despite upregulation in microglia
We have previously reported significant increases in C5aR1 expression on microglia 3 days post-SE. Herein we show that leukocyte infiltration increased after SE (Fig. 1C) , although the percentage of leukocytes expressing C5aR1 did not change between naive, No-SE, and SE animals (Fig. 1B , p > 0.05), including that of neutrophils (CD45 high /Ly6G + ) (data not shown). These results show that infiltrating immune cell C5aR1 expression remains unaltered by pilocarpine SE, unlike that of resident microglia.
C5aR1 deficiency reduced the proportion of infiltrating neutrophils post-SE As reported previously, 4 C5ar1-deficient and wild-type animals did not show any difference in SE onset or characteristics based on behavioral scoring of seizures during SE using a modified Racine scale. We also found that the proportion of infiltrating immune cells (CD45 high ) was significantly increased in forebrains from SE animals compared to No-SE controls. 4 The overall proportion of leukocytes to microglia was similar between C5aR1 genotypes ( Fig. 1C ; two-way analysis of variance [ANOVA] effect of genotype p = 0.77, effect of SE p < 0.05). Of interest, forebrain neutrophil numbers in No-SE were lower and invasion after SE was reduced in C5aR1-deficient mice compared to wildtype by 39% ( Fig. 1D ; two-way ANOVA effect of genotype p < 0.001, effect of SE p < 0.001; Bonferroni post-test p < 0.05), showing that C5aR1 is a key mediator of neutrophil invasion into the CNS after SE.
C5aR1 deficiency led to increased expression of IL-4 by infiltrating leukocytes
We have previously shown that the expression of several cytokines can be affected by C5aR1 deficiency post-pilocarpine SE. 4 Among the cytokines assessed here, namely TNFa, IL-1b, IL-4, IL-6, IL-10, IL-12, Arg, and Ym1, only the antiinflammatory cytokine IL-4 was differentially expressed between genotypes in infiltrating (CD45 high ) leukocytes. C5aR1-deficient SE mice displayed a 39% elevation of IL-4 levels in infiltrating leukocytes compared to wild-type SE animals (two-way ANOVA effect of genotype p = 0.021, effect of SE p = 0.0017; Bonferroni post-test p < 0.05, Fig. 2 ). Analysis of IL-4 expression in CD45 high / Ly6G + neutrophils and in CD45 intermediate microglia was also assessed; however, no significant differences between C5aR1 genotype groups were found (data not shown).
Discussion
Based on our previous report that complement receptor C5aR1 is involved in seizure initiation and worsens the outcomes after SE, such as CA3 pyramidal cell death, 4 we used C5aR1-deficient and wild-type littermates to investigate the role of C5aR1 in altering immune cell phenotypes 3 days after pilocarpine SE. We found reduced neutrophil invasion and increased expression of IL-4 by infiltrating leukocytes in C5aR1-deficient mice, although the number of overall infiltrating leukocytes was unchanged. These two findings point to important mechanisms of C5aR1 that likely contribute to the changes in neuronal survival after SE.
The presence of C5aR1 affects the cytokine profile of infiltrating leukocytes 3 days after pilocarpine SE. We have shown previously that at this time point C5aR1 messenger RNA (mRNA) and protein expression is increased in microglia; however, no changes to the proportion of C5aR1-positive leukocytes were detected. 4 It was shown that protein and mRNA levels of the C5a precursor complement factor 3 (C3) are also increased in epilepsy, 8 suggesting increased presence of circulating C5a and likely complement system activation following acute SE.
We now show here decreased Ly6G + neutrophil invasion post-SE in C5aR1-deficient mice compared to their wild-type counterparts. Given that neutrophils are destructive in nature promoting degranulation, phagocytosis, and production of proapoptotic reactive oxygen species (ROS), reduced invasion to the CNS is likely to lessen neurodegenerative consequences associated with SE. Consistent with this, absence of C5aR1 or its pharmacologic inhibition during pilocarpine SE reduced the extent of degeneration of hippocampal CA1 and CA3 pyramidal cells, 4 suggesting that C5aR1 may promote neutrophil invasion and destruction of neurons. Similarly, increased neutrophil invasion has been linked to worsened outcomes in several CNS diseases including stroke 9 and traumatic brain injury. 10 The second key finding of this study was the upregulation of antiinflammatory IL-4 expression in infiltrating cells of C5aR1-deficient mice post-SE, reinforcing that C5aR1 activation plays a role in the inflammatory response to SE. We previously reported a significant reduction in microglial TNFa expression in C5aR1-deficient mice following SE. 4 Pharmacologic inhibition or absence of C5aR1 during pilocarpine SE reduced death of hippocampal CA1 and CA3 pyramidal cells. 4 Thus taken together in the presence of C5aR1 in the acute period following SE, there was a stronger inflammatory response, potentially contributing to increased neuronal death. It remains to be investigated to which extent pharmacologic blockade of C5aR1 affects cytokine levels.
The potential relevance of IL-4 in epilepsy has been elucidated in human cases, as resected epileptic cortical foci from patients with refractory epilepsy showed high levels of expression of the IL-4 receptor, IL-4Ra, on astrocytes. 11 This suggests that pharmacologic inhibition of C5aR1 may + neutrophils within the CD45 high leukocyte subset was significantly lower in C5aR1-deficient mice post-SE than in their wild-type counterparts (***p < 0.001, n = 12). C5aR1-deficient without SE (No-SE) mice also displayed significantly lower neutrophil invasion (**p < 0.01, n = 12). Two-way ANOVA with Bonferroni post-test used for each analysis. Mean AE standard error of the mean (SEM) shown. Epilepsia ILAE elicit changes to IL-4 in "epileptic" brains that may potentially improve the disease state and its progression. IL-4 is also associated with learning and memory specifically mediated by T-cell regulation of the cytokine. 12 This was illustrated in IL-4-deficient mice, which showed cognitive deficits dependent on T-cell derived IL-4 production, highlighting the functional roles of IL-4 in the brain.
The connection between C5aR1 and suppression of IL-4 increases were thus far unknown in SE, but have been noted before in an asthma study. After challenge with an antigen, mice deficient in C5, the precursor to C5a, had more IL-4-expressing cells in the lungs compared to wild-type mice. 13 The increase in IL-4 levels in the C5aR1-deficient mice could also explain the reduced microglial TNFa levels found in our previous study. 4 This is supported by results showing that in lipopolysaccharide or aggregated b-amyloid-stimulated rat microglia, application of IL-4 led to downregulation of TNFa.
14 In turn, reduced microglial TNFa in C5aR1-deficient brains may promote an IL-4 phenotype of infiltrating cells post-SE.
There are several limitations to this study. We did not use another SE model to confirm our results. In addition, given previous findings that pilocarpine can affect the peripheral inflammatory response, 15 it is important to investigate the peripheral effects of C5aR1 in this model.
In summary, we demonstrated that C5aR1 contributes to the acute inflammatory response elicited by infiltrating immune cells following pilocarpine SE. Together with our previous findings, 4 our studies suggest multiple mechanisms for the protective effects of C5aR1 pharmacologic inhibition or genetic absence. In addition to increased IL-4 expression by infiltrating immune cells and reduced CNS neutrophil invasion, based on previous reports, changes in microglial immune responses 4 and potential changes in the permeability of the BBB 7 may reduce the inflammatory disease state after SE. This signifies that C5aR1 inhibition has beneficial disease-modifying outcomes after SE due to the alteration of several immune pathways.
Statistical methods
All statistical analysis was performed using GraphPad Prism 7.0 software (San Diego, CA, U.S.A.). Specific tests used for each dataset are outlined in the figure legends. p-Values ≤0.05 were considered significant (*p < 0.05; **p < 0.01; ***p < 0.001). The ratio of infiltrating leukocytes expressing antiinflammatory IL-4 was 39% higher in C5aR1-deficient mice compared to No-SE and naive controls (*p < 0.05, n = 12 mice per group). All data were expressed as a normalized fold change from naive control levels, represented by the dotted line. Median fluorescence intensity (MFI) was used as a measure to delineate positive cell populations. Two-way ANOVA with Bonferroni post-test was used. Epilepsia ILAE
